MedPath

Clinical efficacy of FGLM-NH2+SSSR eye drops for intractable corneal epithelial disorders

Phase 2
Recruiting
Conditions
Persistent epithelial defect
Registration Number
JPRN-jRCTs061180036
Lead Sponsor
Kimura Kazuhiro
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
165
Inclusion Criteria

1.The presence of persistent epithelial defect by slit-lamp
examination resistant to conventional treatments for more
than 1 week
2.male and female
3.age >= 20years
4.Patients provided written, informed consent to participate

Exclusion Criteria

1. Are pregnant or may possibly be pregnant
2. In breast-feeding women
3. Drug allergies for this agents
4. Were judged an inadequate subject to enrollment by a medical doctor

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Time to complete healing for persistent epithelial defect
Secondary Outcome Measures
NameTimeMethod
Visual acuity<br>Safety
© Copyright 2025. All Rights Reserved by MedPath